A minimalistic approach for transfemoral transcatheter aortic valve implantation therapy: a prospective "real-world" study

Heart, Artery and Coronary DiseasesTherapy and Intervention

The Reversibility of Cardiac Damage After Transcatheter Aortic Valve Implantation and Short-Term Outcomes in a Real-World Setting

Eur Heart J Cardiovasc Imaging

Myagmardorj R, Fortuni F, Généreux P, Nabeta T, Stassen J, Galloo X, Meucci MC, Butcher S, van der Kley F, Cohen DJ, Clavel MA, Pibarot P, Leon MB, Regeer MV, Delgado V, Ajmone Marsan N, Bax JJ

doi: 10.1093/ehjci/jeaf045

Further Publications

Cardiac implantable electronic device carriers undergoing transcatheter tricuspid valve annuloplasty: real-world insights

Clin Res Cardiol

Wrobel JM, Kirchner J, Friedrichs K, Gietzen T, Althoff J, Hasse C, von Stein P, Wörmann J, von Stein J, Curio J, Rudolph F, Ivannikova M, Iliadis C, Steven D, Baldus S, Rudolph V, Pfister R, Gerçek M, Koerber MI

doi: 10.1007/s00392-025-02616-5

Heart, Artery and Coronary DiseasesTherapy and Intervention

Outcomes of Transcatheter Aortic Valve Replacement in Low-Risk Patients in the United States: A Report From the STS/ACC TVT Registry

Circulation

Vekstein AM, Wegermann ZK, Manandhar P, Mack MJ, Cohen DJ, Hughes GC, Harrison JK, Kaneko T, Kapadia SR, Stathogiannis K, Fearon WF, Arnold S, Kosinski AS, Leon MB, Batchelor WB, Thourani VH, Vemulapalli S

doi: 10.1161/CIRCULATIONAHA.124.071838

Heart Failure

Real-world outcomes in cardiac resynchronization therapy patients: Primary results of the SMART registry

ESC Heart Fail

García-Bolao I, Gardner RS, Gras D, D'Onofrio A, Mark G, Nair D, Lellouche N, Novak M, Lo R, Chew E, Wright D, Kaplan A, Bertini M, Veraghtert S, Harbin MM, Matznick E, Yong P, Stein KM

doi: 10.1002/ehf2.15190

Heart Failure

Prognosis After >50% Decline in eGFR in Heart Failure Patients: A Nationwide Real-World Study

JACC Heart Fail

Anjum DZ, Elmegaard M, Garred CH, Nouhravesh N, Fosbol E, Jhund PS, McMurray JJV, Petrie MC, Køber L, Schou M

doi: 10.1016/j.jchf.2025.02.027

Heart Failure

Real-world use of guideline-directed therapy for heart failure: Insights from the Danish Heart Failure Registry

ESC Heart Fail

Schjødt I, Valentin JB, Johnsen SP, Mols RE, Egstrup K, Løgstrup BB

doi: 10.1002/ehf2.15320

Cardiovascular Risk and Diseases

Low serum 1,5-anhydroglucitol is associated with increased risk of all-cause and cardiovascular mortality in type 2 diabetes: A real-world cohort study

Diabetes Obes Metab

Ni J, Chen L, Su H, Cai J, Wang C, Lu W, Wang Y, Lu J, Xia T, Zhou J

doi: 10.1111/dom.70214

Heart, Artery and Coronary Diseases

Association between SSRI use and cardiovascular outcomes in patients with coronary artery disease and generalized anxiety disorder: A real-world cohort study

Atherosclerosis

Wu JY, Chang HY, Kao CL, Hung KC, Yu T, Lin YM

doi: 10.1016/j.atherosclerosis.2025.120390

Heart Failure

Impact of glp-1 receptor agonists on hospitalization for heart failure and all-cause death in patients with diabetes with and without heart failure: a real-world study

Clin Res Cardiol

Ojeda-Fernández L, Torrigiani G, Molteni M, Fortino I, Cimminiello C, Baviera M

doi: 10.1007/s00392-025-02674-9

Related content

The Reversibility of Cardiac Damage After Transcatheter Aortic Valve Implantation and Short-Term Outcomes in a Real-World Setting

Cardiac implantable electronic device carriers undergoing transcatheter tricuspid valve annuloplasty: real-world insights

Outcomes of Transcatheter Aortic Valve Replacement in Low-Risk Patients in the United States: A Report From the STS/ACC TVT Registry

Real-world outcomes in cardiac resynchronization therapy patients: Primary results of the SMART registry

Prognosis After >50% Decline in eGFR in Heart Failure Patients: A Nationwide Real-World Study

Real-world use of guideline-directed therapy for heart failure: Insights from the Danish Heart Failure Registry

Low serum 1,5-anhydroglucitol is associated with increased risk of all-cause and cardiovascular mortality in type 2 diabetes: A real-world cohort study

Association between SSRI use and cardiovascular outcomes in patients with coronary artery disease and generalized anxiety disorder: A real-world cohort study

Impact of glp-1 receptor agonists on hospitalization for heart failure and all-cause death in patients with diabetes with and without heart failure: a real-world study